Mahvish Muzaffar MD, Rekha Chaudhary MD, Xin Li MD, Shobha Ratnam MD
{"title":"Post-renal transplant plasma cell dyscrasia presenting as retroperitoneal plasmacytoma: A case report and literature review","authors":"Mahvish Muzaffar MD, Rekha Chaudhary MD, Xin Li MD, Shobha Ratnam MD","doi":"10.1002/dat.20539","DOIUrl":null,"url":null,"abstract":"<p>Post-transplant lymphoproliferative disease (PTLD) is a rare but potentially fatal complication of organ transplanta-tion. Most cases of PTLD represent Epstein Barr virus (EBV)-related B-cell disease in a setting of pharmacological immunosuppression. Post-transplant plasma cell dyscrasia is very rare, and post-transplant plasma cell dyscrasia with extramedullary plasmacytoma is extremely rare. We report here a case of the latter, which to our knowledge is the fourth such reported case in the English literature. A 22-year-old man developed post-transplant plasma cell dyscrasia 20 years after a renal transplant while on immunosuppression. His presentation included retroperitoneal plasmacytoma, which is very rare and is probably the first case in a renal transplant patient. The patient is in complete remission 1 year after receiving five cycles of bortezomib and dexamethasone.</p>","PeriodicalId":51012,"journal":{"name":"Dialysis & Transplantation","volume":"40 3","pages":"130-132"},"PeriodicalIF":0.0000,"publicationDate":"2011-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/dat.20539","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dialysis & Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/dat.20539","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Post-transplant lymphoproliferative disease (PTLD) is a rare but potentially fatal complication of organ transplanta-tion. Most cases of PTLD represent Epstein Barr virus (EBV)-related B-cell disease in a setting of pharmacological immunosuppression. Post-transplant plasma cell dyscrasia is very rare, and post-transplant plasma cell dyscrasia with extramedullary plasmacytoma is extremely rare. We report here a case of the latter, which to our knowledge is the fourth such reported case in the English literature. A 22-year-old man developed post-transplant plasma cell dyscrasia 20 years after a renal transplant while on immunosuppression. His presentation included retroperitoneal plasmacytoma, which is very rare and is probably the first case in a renal transplant patient. The patient is in complete remission 1 year after receiving five cycles of bortezomib and dexamethasone.